posts browsing tag

macrogen

The Korean biotech company Macrogen (CEO Sukang Lee) (KOSDAQ: 038290), announced that it obtained export approval for the COVID-19 test kit ‘AxenTM COVID-19 RT’ from the Ministry of Food and Drug Safety (MFDS) on the 18th.  Macrogen’s COVID-19 test kit is a product that uses RT …

Continue reading

As the molecular road map and blueprint of human biology, a single genome contains all the information required to build, maintain and repair a human being. Since the successful mapping of the human genome in 2003, mankind’s elevated understanding of how approximately 3 billion base pairs of deoxyribonucleic acid …

Continue reading

ROCKVILLE, MD–On January 2nd, the Psomagen–Macrogen Consortium announced the acquisition of all key assets of US company uBiome. Through the move, Psomagen has become a key player in the microbiome sector, a promising next-generation bio healthcare industry, with a competitive advantage in the US and …

Continue reading

– The largest number of regions and races included in any Asian reference panel – Identification of genome diversity within Asian ethnic groups and differences in drug response SEOUL, South Korea–The precision medicine and biotechnology company Macrogen (Chairman Jung-Sun Seo) (KOSDAQ: 038290) announced on Dec 4 that …

Continue reading

– Patent granted for blockchain technology for data transaction brokerage and sharing between data providers and users – Allows individuals to have control over their healthcare data – Technology to be used by Psomagen to build healthcare big data for the U.S. DTC market SEOUL, South Korea— The precision …

Continue reading